Download presentation
1 -

Gopi Shankar


PhD MBA FAAPSLarge PharmaJanssen BioTherapeuticsGopi ShankarMS PhD MBA FAAPS isVice Presidentand Head of Biologics Development Sciences BDSwithin Janssen BioTherapeuticsJBIO Janssen Research Develop

elysha's Recent Documents

Buildings and Grounds Management
Buildings and Grounds Management

EBEBAll district buildings and property shall be maintained and inspected on a regular basisApprovedEB-RBuildings and Grounds ManagementEB-RThe director of buildings and grounds shall prepare for the

published 0K
UFormStatementExpensesCj4tllWhatDescribe501mannerorganizationseachprog
UFormStatementExpensesCj4tllWhatDescribe501mannerorganizationseachprog

4333dcYesthedescriptionattachbusinessnotaDidthe6033this-the37aperiodbyincludedsectionSectionorganizationEntertheSection501organizationpartyo---------------aSeeorganizationSectionqand143thedonorcomplet

published 0K
Tips for Using NLM146s PubMedpubmedncbinlmnihgovHowo Find a KnownArtic
Tips for Using NLM146s PubMedpubmedncbinlmnihgovHowo Find a KnownArtic

PubMed CentralPMCwwwncbinlmnihgov/pmc/When full text is available in PubMed Central the Free in PMC icon will appear on the citations abstract display under FullText Links Click the icon to view the a

published 0K
Islamism and the International Order
Islamism and the International Order

Hoover Institution Stanford University 434 Galvez MallStanford CA 94305-6003650-723-1754Hoover Institution in Washington The Johnson Center1399 New York Avenue NW Suite 500 Washington DC 20005202-760-

published 0K
STATEMENT STARTING INFORMAL PROBATE
STATEMENT STARTING INFORMAL PROBATE

Page 1of 2AS 1316115P-316 5/21csAND APPOINTING A PERSONAL REPRESENTATIVE WHEN THERE IS A WILLIN THE SUPERIOR COURT FOR THE STATE OF ALASKAAT In the Matter of the Estate ofPerson Who Died DecedentDate

published 0K
ffATIEBCSe
ffATIEBCSe

i I-was Urn tHesame a th I-I a i a relation a a a- - - b tfThe rf flie TClm H imm tt mtwk fMt txan w mGmfjmi X wasi 9- i A m 4WQ - a- ri M a fisckiiiRii-mmmmff ItKunit- witmm A ytfimmpIn Mutua

published 0K
Housing Support Staff 3
Housing Support Staff 3

rdShiftPreble Street has full-time 3rd shift Housing Support Staff openingThe Housing Support Staff will be responsible for providing program coverage maintaining tenant safety monitoring the security

published 0K
is one reason utilities are already showing so much interest in effici
is one reason utilities are already showing so much interest in effici

we all just properly inflated our tires and maintained our engines we could save as much oil now as newoffshore drilling would produce by 2030 And since buildings devour two-thirds of our power commer

published 0K
Download Section

Download - The PPT/PDF document "" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.






Document on Subject : "Gopi Shankar"— Transcript:

1 Gopi Shankar , Ph.D., MBA, FAAPS Large
Gopi Shankar , Ph.D., MBA, FAAPS Large Pharma Janssen BioTherapeutics Gopi Shankar, M.S., Ph.D., MBA, FAAPS, is Vice President and Head of Biologics Development Sciences (BDS) within Janssen BioTherapeutics (JBIO), Janssen Research & Development (JRD) . He leads a global team of scientists who contribute to scientific and operational deliverables across the areas of biophysics, translational pharmacology and model - guided drug design, and bioanalytical science s . He is based in Spring House, PA. Gopi earned an M.S. in Molecular Biology from Oklahoma State University, a Ph.D. in Immunology from University of Kentucky, a Certificate in Biomedical Regulatory Affairs from the University of Washington, and an MBA i n Leadership and General Management from Drexel University. Following a post - doctoral tenure, he managed Quality Control & Immune Monitoring at Northwest Biotherapeutics (Seattle, WA) from 1999 to 2002. He then joined Centocor as a Senior Research Scientis t overseeing clinical immunogenicity . Subsequently he assumed progressively greater responsibilities for immunogenicity and the b ioanalytical l aboratory, supporting biologics development at JRD - from preclinical through post - market studies. A world - renowned expert in the field of immunogenicity, Gopi has published in the areas of basic immunological research and technical, strategic and regulatory best practices. He has led or contributed to s everal highly cited articles on immunogenicity, including 6 industry whitepapers and a chapter in the United States Pharmacopeia. During his career , Gopi has focused on the development of fit - for - purpose s olutions to scientific problems . He has also buil t consensus for and harmonized scientific practices within drug development , many of which have been adopted by regulatory agencies in their public scientific guidance documents. These approaches include anti - drug antibody detection methods development and validation, resolution of assay interferences to improve accuracy, quality control of bioanalytical reagents, and the establishment of terminology and analytical approaches for clinical immunogenicity. His research, consensus - building efforts and best - pra ctice publications, both independently and via AAPS, have transformed the thinking and tactical processes related to immunogenicity around the globe. For his contributions to pharmaceutical science, the American Association of Pharmaceutical Scientists ( AAPS ) conferred Fellow status to him in 2015. In 2019 he was elected as a Member - at - Large to serve on the AAPS Board of Directors.